Richard Douglas

Richard Douglas is the current advisor at Red Sky Partners. Prior to this, they worked at Aldeyra Therapeutics, Labyrinth Choir, Novavax, University of Michigan - Technology Transfer, and Genzyme. Douglas began their career in 1982 at Genzyme where they worked for 29 years, eventually becoming Senior Vice President of Corporate Development. In 2011, Douglas left Genzyme to pursue other opportunities. Richard has since held positions at various companies before taking their current role as advisor at Red Sky Partners.

Richard Douglas earned a PhD in Biochemistry from the University of California, Berkeley and a BS in Chemistry from the University of Michigan.